On air · 1 of 3 networks
Medicines and Healthcare products Regulatory Agency
- gov.uk
- GB
- 1,754 employees
Medicines and Healthcare products Regulatory Agency’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 31. Watch Medicines and Healthcare products Regulatory Agency with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 18 | Checked 29 Oct 2026 | See all 31 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 23 Oct 2026 | Collect them with the API → |
| Not checked | — |
Medicines and Healthcare products Regulatory Agency has 18 live LinkedIn ads. Its Facebook page had no active ads on 23 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 12 Oct 2026
Discover how global collaboration is shaping the future of healthcare innovation From AI and health data to advanced therapies and rare diseases, healthcare innovation increasingly depends on global collaboration. Discover how regulators, researchers, healthcare leaders and innovators are working together to accelerate access to new treatments, improve patient outcomes and shape the future of healthcare worldwide. Featured speakers include: > Dr. Alison Cave, MHRA > Professor Dr. David Fajgenbaum, MD, MBA, MSc, Every Cure > H.E. Dr. Hisham Saad Aljadhey, Saudi Food and Drug Authority (SFDA) > Dr. William Warr PhD OBE, BioNTech Build the knowledge and connections needed to help shape the next generation of healthcare innovation. ➡️ Secure your place today https://lnkd.in/eK38Mgcz #artificialintelligence #healthdata #advancedtherapies #rarediseases #healthcareinnovation #futureleadership #patientoutcomes #globalcollaboration
- LINKEDIN · IMAGESince 9 Oct 2026
Learn from the leaders shaping the future of global regulation As healthcare innovation becomes increasingly global, collaboration between regulators, industry and innovators has never been more important. Discover how international partnerships, regulatory cooperation and shared innovation are helping to shape more agile, effective and globally connected healthcare systems. Featured speakers include: > James Pound, MHRA > Daniel O'Connor, ABPI > H.E. Dr. Hisham Saad Aljadhey, Saudi Food and Drug Authority (SFDA) > Pam Aung Thin, Health Canada > Professor Tony Lawler, Therapeutic Goods Administration (TGA) > Vincenza Trivigno, Swissmedic Stay ahead of the trends shaping global healthcare and regulatory innovation. ➡️ Book your place today https://lnkd.in/eK38Mgcz #GlobalRegulation #InternationalCollaboration #RegulatoryInnovation #Policy #Leadership #RegulatoryConvergence
- LINKEDIN · IMAGESince 7 Oct 2026
We are delighted to announce that Lord David Cameron will headline the inaugural DIA-MHRA Global Summit as a keynote speaker. Bringing together regulators, industry leaders, policymakers, researchers and innovators from across the world, the Summit will provide a unique forum to explore the future of healthcare regulation, life sciences innovation and international collaboration. As former Prime Minister and Foreign Secretary, Lord Cameron brings unparalleled experience of global leadership, diplomacy and international partnership. But beyond politics, Lord Cameron is also deeply invested in advancing scientific and medical innovation - having a deep personal interest in the rare disease landscape having had a son with a rare and incurable disease, which led him to launch the UK’s 100,000 Genomes Project and Genomics England when he was Prime Minister. He now chairs the Advisory Council of the Oxford-Harrington Rare Disease Centre. Lord Cameron's session will offer valuable insights into the role that collaboration and strategic partnerships can play in addressing shared global health challenges and supporting innovation for patients. The DIA-MHRA Global Summit will convene leading voices from across the medicines and healthtech industries together with speakers from academia, investment and wider healthcare ecosystem to discuss the opportunities and challenges shaping the future regulatory landscape. 📅 Register now and join us for this landmark event https://lnkd.in/eKK6kG6y #DIAMHRA2026 #LifeSciences #HealthcareInnovation #Regulation #GlobalHealth #MedTech #Pharma #MHRA #DIA
- LINKEDIN · IMAGESince 6 Oct 2026
Build your knowledge and skills and shape the future of healthcare innovation Healthcare is evolving rapidly through advances in AI, data, advanced therapies and regulatory science. Join experts from across healthcare, regulation and industry to explore the opportunities and challenges that will define the next generation of innovation. Featured speakers include: > Lawrence Tallon, MHRA > Lord Willetts, UK Regulatory Innovation Office > Dame Jennifer Dixon, Health Foundation > Dr. Melanie Ivarsson OBE Ivarsson, Health Data Research Service (HDRS) Gain the insights, connections and perspectives shaping the next generation of healthcare leaders. ➡️ Register now https://lnkd.in/eKK6kG6y #AI #Data #Innovation #RegulatoryScience #ProfessionalDevelopment
- LINKEDIN · IMAGESince 6 Oct 2026
What will shape health innovation over the next decade? Join regulators, industry leaders, investors and healthcare innovators to explore the strategic decisions shaping the future of healthcare and life sciences. Featured speakers include: > Lawrence Tallon, MHRA > Sir John Bell, Our Future Health > Dame Kate Bingham, SV Health Investors > Dr. Melanie Ivarsson OBE, Health Data Research Service (HDRS) The decisions shaping tomorrow's healthcare ecosystem are being discussed today. ➡️ Register now https://lnkd.in/eKK6kG6y #AI #advancedtherapies #regulation #investment #patientaccess
- LINKEDIN · IMAGESince 6 Oct 2026
Where will the next wave of life sciences growth come from? Explore the intersection of investment, policy, innovation and regulation with leaders from government, industry and investors. Featured speakers include: > Prof. Chris Molloy, BIA > Dame Kate Bingham, SV Health Investors > Dr Annalisa Jenkins OBE, The Conscience Collective and Genomics England Understand and influence where capital, talent and innovation go next. ➡️ Secure your place https://lnkd.in/eKK6kG6y #UKcompetitiveness #capital #marketgrowth #innovationpolicy
6 of 31 adsSign up to see every Medicines and Healthcare products Regulatory Agency ad, filter by format and date, and get alerts on new ones.
See all 31 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.